FDA slaps hold on Zolgensma trials as animal data raises safety questionThe FDA has placed a partial clinical hold on Novartis’ recently-approved gene therapy Zolgensma for spinal muscular atrophy Share XFDA slaps hold on Zolgensma trials as animal data raises safety questionhttps://pharmaphorum.com/news/fda-slaps-hold-on-zolgensma-trials-as-animal-data-raises-safety-question/
Major US retailers pull J&J’s talc from shelves over asbestos fearsA trio of major US retailers including Walmart are removing all 22-ounce bottles of Johnson & Johnson’s baby Share XMajor US retailers pull J&J’s talc from shelves over asbestos fearshttps://pharmaphorum.com/news/major-us-retailers-pull-jjs-talc-from-shelves-over-asbestos-fears/
Lawsuit-laden J&J recalls baby powder after asbestos alertJohnson & Johnson has said it is recalling around 33,000 bottles of baby powder in the US, after Share XLawsuit-laden J&J recalls baby powder after asbestos alerthttps://pharmaphorum.com/news/lawsuit-laden-jj-recalls-baby-powder-after-asbestos-alert/
Multiple pharmas pull ranitidine stomach drugs amid growing cancer scareSupplies of the heartburn drug ranitidine have been recalled globally following a cancer scare involving multiple pharma companies, Share XMultiple pharmas pull ranitidine stomach drugs amid growing cancer scarehttps://pharmaphorum.com/news/multiple-pharmas-pull-ranitidine-stomach-drugs-amid-growing-cancer-scare/
France’s Servier finally goes on trial over Mediator safety scandalMore than a decade after a scandal over drug safety in France first broke, the pharma company Servier Share XFrance’s Servier finally goes on trial over Mediator safety scandalhttps://pharmaphorum.com/news/frances-servier-finally-goes-on-trial-over-mediator-safety-scandal/
EU safety experts begin review of leuprorelin-containing drugsEuropean safety experts are to begin a review of leuprorelin-containing medicines, commonly used in breast and prostate cancer Share XEU safety experts begin review of leuprorelin-containing drugshttps://pharmaphorum.com/news/eu-safety-experts-begin-review-of-leuprorelin-containing-drugs/
Teva expands blood pressure drug recall in the US amid cancer fearsTeva has expanded a recall of losartan potassium tablets after tests revealed a potential human carcinogen in the Share XTeva expands blood pressure drug recall in the US amid cancer fearshttps://pharmaphorum.com/news/teva-expands-blood-pressure-drug-recall-in-the-us-amid-cancer-fears/
Lilly moves Crohn’s drug into phase 3, faces safety setback in JapanEli Lilly has had a mixed few days, posting promising trial results for mid-stage Crohn’s disease drug mirikizumab, Share XLilly moves Crohn’s drug into phase 3, faces safety setback in Japanhttps://pharmaphorum.com/news/lilly-moves-crohns-drug-mirikizumab/
EU regulators slap safety restriction on Pfizer’s XeljanzEuropean safety regulators have placed restrictions on Pfizer’s Xeljanz, saying it should not be used in the higher Share XEU regulators slap safety restriction on Pfizer’s Xeljanzhttps://pharmaphorum.com/news/eu-regulators-slap-safety-restriction-on-pfizers-xeljanz/
